EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Central nervous system lymphomas—Assessment and treatment and prevention of central nervous system relapse

Paola Ghione iD, Katharine L Lewis, Sabela Bobillo, Laksmi Nayak, Elisabeth Schorb, Lucia Nichelli, Andrea Ng, Kerry J Savage, Pam McKay, Loretta Nastoupil, Carole Soussain, Kate Cwynarski

Hematological Oncology · 2024

DOI: 10.1002/hon.3197 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Hematological Oncology, 2024. Verfasst von Paola Ghione und 11 weiteren Autor:innen. Beteiligte Einrichtung: Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Central Nervous System Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 101 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this review focused on lymphoma and the central nervous system (CNS), we summarize recent developments in the management of primary (PCNSL) and secondary CNS lymphoma (SCNSL), treatment of CNS lymphoma in the older population, the neuroradiological assessment of CNS lymphoma and finally highlight the ongoing debate on optimal CNS prophylaxis. The section on PCNSL focuses on the different approaches available for frontline treatment in Europe and the United States and discusses consolidation strategies. We then highlight available strategies to treat PCNSL in the elderly population, an area of unmet need. New therapies aiming at minimizing toxicity and prioritizing quality of life are emerging for these patients. Secondary CNS lymphoma, especially in the relapsed/refractory setting is another area of unmet need, and the efficacy of CAR‐T cell therapy is being explored. We provide an overview of the imaging challenges in the neuroradiological assessment of CNS lymphoma. Finally, the section on CNS prophylaxis summarizes recent findings from large retrospective studies challenging the efficacy of present approaches to prophylaxis in higher‐risk patients with lymphoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Nervous System NeoplasmsHumansNeoplasm Recurrence, LocalLymphomaDisease Management

Stichwörter der Autor:innen

CNS lymphomaCNS prophylaxiselderly CNS

Autor:innen und Institutionen

  • Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Sir Charles Gairdner Hospital and Linear Clinical Research, Nedlands, Western Australia, Australia.
  • University Hospital Val D'Hebron, Barcellona, Spain.
  • Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • Department of Hematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Hôpitaux Universitaires La Pitié Salpêtrière, Paris, France.

ORCID-Profile: Paola Ghione

Zitieren

APA

Ghione, P., Lewis, K. L., Bobillo, S., Nayak, L., Schorb, E., Nichelli, L., Ng, A., Savage, K. J., McKay, P., Nastoupil, L., Soussain, C., & Cwynarski, K. (2024). Central nervous system lymphomas—Assessment and treatment and prevention of central nervous system relapse. Hematological Oncology. https://doi.org/10.1002/hon.3197

Vancouver

Ghione P, Lewis KL, Bobillo S, Nayak L, Schorb E, Nichelli L, et al. Central nervous system lymphomas—Assessment and treatment and prevention of central nervous system relapse. Hematological Oncology. 2024. doi:10.1002/hon.3197

BibTeX
@article{Ghione2024,
  author = {Ghione, Paola and Lewis, Katharine L and Bobillo, Sabela and Nayak, Laksmi and Schorb, Elisabeth and Nichelli, Lucia and Ng, Andrea and Savage, Kerry J and McKay, Pam and Nastoupil, Loretta and Soussain, Carole and Cwynarski, Kate},
  title = {Central nervous system lymphomas—Assessment and treatment and prevention of central nervous system relapse},
  journal = {Hematological Oncology},
  year = {2024},
  doi = {10.1002/hon.3197}
}
Kostenlos starten →